We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CETX icon
5251
Cemtrex
CETX
$5.09M
-2
Closed -$256
CGGR icon
5252
Capital Group Growth ETF
CGGR
$25B
-34
Closed -$1.38K
CGSM icon
5253
Capital Group Short Duration Municipal Income ETF
CGSM
$1.57B
-550
Closed -$14.3K
CHCI icon
5254
Comstock Holding Companies
CHCI
$154M
-135
Closed -$1.36K
CHGG icon
5255
Chegg
CHGG
$95.8M
-79,497
Closed -$96.2K
CHX
5256
DELISTED
ChampionX
CHX
-25,712
Closed -$639K
CII icon
5257
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
-4
Closed -$85
CIGI icon
5258
Colliers International
CIGI
$5.06B
-738
Closed -$96.3K
CING icon
5259
Cingulate
CING
$69.5M
-1,701
Closed -$6.92K
CLDI icon
5260
Calidi Biotherapeutics
CLDI
$4.01M
-47
Closed -$2.06K
CLNN icon
5261
Clene
CLNN
$58M
-1,153
Closed -$4.51K
CLSD
5262
DELISTED
Clearside Biomedical
CLSD
-54
Closed -$648
CNRG icon
5263
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$205M
-4,207
Closed -$250K
CNSP icon
5264
CNS Pharmaceuticals
CNSP
$7.29M
-562
Closed -$5.56K
CNTX icon
5265
Context Therapeutics
CNTX
$41.9M
-7,414
Closed -$4.86K
CODA icon
5266
Coda Octopus Group
CODA
$117M
-579
Closed -$4.74K
ZSQR
5267
Z Squared Inc
ZSQR
$204M
-268
Closed -$2.09K
CONY icon
5268
YieldMax COIN Option Income Strategy ETF
CONY
$329M
-2,143
Closed -$196K
COSM icon
5269
Cosmos Holdings
COSM
$14M
-3,725
Closed -$1.56K
CPHI icon
5270
China Pharma Holdings
CPHI
$45M
-8,213
Closed -$14.7K
CRBP icon
5271
Corbus Pharmaceuticals
CRBP
$179M
-4,833
Closed -$33.3K
CREV
5272
DELISTED
Carbon Revolution
CREV
-565
Closed -$1.59K
CRGX
5273
DELISTED
CARGO Therapeutics
CRGX
-5,879
Closed -$24.2K
CRNT icon
5274
Ceragon Networks
CRNT
$195M
-5,907
Closed -$14.5K
CSAN icon
5275
Cosan
CSAN
$2.77B
-1,899
Closed -$9.59K

Similar funds

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.